CCI vs EW · P/E 40, rev $6.57B vs P/E 47, rev $1.39B
Crown Castle (CCI) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CCI and EW stock pages for the full models.
Not investment advice.